Skip to main content
Log in

Resumption of ovarian function after 4 years of estro-progestin treatment in a young woman with Crohn’s disease and premature ovarian insufficiency: a case report

  • Gonadal Physiology and Disease
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To report the long-term management of a case of premature ovarian insufficiency of unknown origin in a young woman with Crohn’s disease.

Method

Here is reported the case of a 20 years old woman with Cronh’s disease presenting with two years amenorrhea and FSH and LH levels of 255 mIU/ml and 182 mIU/ml respectively, who received 10 months corticosteroid treatment followed by 7 years of estro-progestin treatment.

Results

Corticosteroid treatment was ineffective in restoring patients gonadotropin levels as well as ovarian volume, while estro-progestins promoted a prompt reduction in gonadotrophin levels, which returned in the normal range after two years of treatment, as well as restoration of ovarian function, which occurred after four years of estrogens administration, as demonstrated by normal ovarian volume and ovulatory follicles at ultrasound, and by the re-establishment of regular menses after estroprogestin discontinuation.

Conclusions

Long-term suppression of the endogenous gonadotropins using estroprogestins may be suggested as a treatment able to restore ovarian responsiveness even in patients with premature ovarian insufficiency showing highly elevated gonadotropin levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Anasti JN, Kimzey LM, Defensor RA, White B, Nelson LM. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil Steril. 1994;62:726–30.

    PubMed  CAS  Google Scholar 

  2. Badawy A, Goda H, Ragab A. Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reprod Biomed Online. 2007;15:215–9.

    Article  PubMed  CAS  Google Scholar 

  3. Barbarino-Monnier P, Gobert B, Guillet-May F, Bene MC, Barbarino A, Foliguet B, Faure GC. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod. 1995;10:2006–7.

    PubMed  CAS  Google Scholar 

  4. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;6:1–9.

    Google Scholar 

  5. Bidet M, Bachelot A, Bissauge E, Golmard JL, Gricourt S, Dulon J, Coussieu C, Badachi Y, Touraine P. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab. 2011;96:3864–72.

    Article  PubMed  CAS  Google Scholar 

  6. Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril. 1993;59:988–91.

    PubMed  CAS  Google Scholar 

  7. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.

    PubMed  CAS  Google Scholar 

  8. Couse JF, Yates MM, Walker VR, Korach KS. Characterization of the hypothalamic-pituitary-gonadal axis in Estrogen Receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ER but not ER. Mol Endocrinol. 2003;17:1039–53.

    Article  PubMed  CAS  Google Scholar 

  9. Cowchock FS, McCabe JL, Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol. 1988;158:118–9.

    PubMed  CAS  Google Scholar 

  10. Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S. Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecol Endocrinol. 2009;25:769–72.

    Article  PubMed  Google Scholar 

  11. Forges T, Monnier-Barbarino P, Faure GC, Benè MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Updat. 2004;10:163–75.

    Article  CAS  Google Scholar 

  12. Gordon A, Aguilar R, Garrido-Gracia JC, Guil-Luna S, Sa’nchez-Cespedes R, Millan Y, de las Mulas JM, Sanchez-Criado JE. Activation of estrogen receptor-a induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats. Hum Reprod. 2009;24:2618–28.

    Article  PubMed  CAS  Google Scholar 

  13. Kallio S, Aittomaki K, Piltonen T, Veijola R, Liakka A, Vaskivuo TE, Dunkel L, Tapanainen JS. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum Reprod. 2012;27:854–60.

    Article  PubMed  CAS  Google Scholar 

  14. Laml T, Huber JC, Albrecht AE, Sintenis WA, Hartmann BW. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea. Gynecol Endocrinol. 1999;13:89–92.

    Article  PubMed  CAS  Google Scholar 

  15. La Marca A, Marzotti S, Brozzetti A, Stabile G, Artenisio AC, Bini V, Giordano R, De Bellis A, Volpe A, Falorni A, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab. 2009;94:3816–23.

    Article  PubMed  Google Scholar 

  16. Lv X, Shi D. Combined effects of levonorgestrel and quinestrol on reproductive hormone levels and receptor expression in females of the Mongolian gerbil (Meriones unguiculatus). Zoolog Sci. 2012;9:37–42.

    Article  Google Scholar 

  17. Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril. 1992;57:50–5.

    PubMed  CAS  Google Scholar 

  18. Neves-e-Castro M. An estrogen treatment may reverse a premature ovarian failure. Fertil Steril. 2009;91:e1.

    Article  PubMed  Google Scholar 

  19. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. 2007;87:858–61.

    Article  PubMed  CAS  Google Scholar 

  20. van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–92.

    Article  PubMed  Google Scholar 

  21. van Kasteren YM, Braat DDM, Hemrika DJ, Lambalk CB, Rekers-Mombarg LTM, von Blomberg BME, Schoemaker J. Corticosteroids do not influence responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. 1999;71:90–5.

    Article  PubMed  Google Scholar 

  22. Yin W, Gore AC. Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction. 2006;131:403–14.

    Article  PubMed  CAS  Google Scholar 

  23. Yin W, Wu D, Noel ML, Gore AC. Gonadotropin-releasing hormone neuroterminals and their microenvironment in the median eminence: effects of aging and estradiol treatment. Endocrinology. 2009;150:5498–508.

    Article  PubMed  CAS  Google Scholar 

  24. Zargar AH, Salahuddin M, Wani AI, Bashir MI, Masoodi SR, Laway BA. Pregnancy in premature ovarian failure: a possible role of estrogen plus progesterone treatment. J Assoc Phys India. 2000;48:213–5.

    CAS  Google Scholar 

Download references

Conflict of interest statement and funding

The authors declare that they have no conflict of interest. This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ettore Caroppo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caroppo, E., D’Amato, G. Resumption of ovarian function after 4 years of estro-progestin treatment in a young woman with Crohn’s disease and premature ovarian insufficiency: a case report. J Assist Reprod Genet 29, 973–977 (2012). https://doi.org/10.1007/s10815-012-9816-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9816-9

Keywords

Navigation